Whitebox Advisors’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Whitebox Advisors’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-250,000	Closed	-$75K	–	377
2023 Q4	$75K	Hold	250,000	–	–	﹤0.01%	140
2023 Q3	$87.3K	Hold	250,000	–	–	﹤0.01%	146
2023 Q2	$40K	Hold	250,000	–	–	﹤0.01%	186
2023 Q1	$36.3K	Hold	250,000	–	–	﹤0.01%	283
2022 Q4	$15K	Hold	250,000	–	–	﹤0.01%	470
2022 Q3	$10K	Hold	250,000	–	–	﹤0.01%	642
2022 Q2	$28K	Hold	250,000	–	–	﹤0.01%	558
2022 Q1	$45K	Hold	250,000	–	–	﹤0.01%	608
2021 Q4	$80K	Buy	+250,000	New	+$79.1K	﹤0.01%	579

Whitebox Advisors's DMAQR Position: Q1 2024 in Review

Whitebox Advisors sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 250,000 shares — an estimated $75K sold.

Whitebox Advisors first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $87.3K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Whitebox Advisors reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Whitebox Advisors sold 250,000 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $75K.
Whitebox Advisors first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Whitebox Advisors's Deep Medicine Acquisition Corp. Rights position peaked at $87.3K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Whitebox Advisors's 13F filing for Q1 2024, filed 15 May 2024.